Targeting TRAIL death receptor 4 with trivalent DR4 Atrimer complexes.

Targeting TRAIL death receptor 4 with trivalent DR4 Atrimer complexes.

Item
http://www.wikidata.org/entity/Q34339275
Sorafenib sensitizes solid tumors to Apo2L/TRAIL and Apo2L/TRAIL receptor agonist antibodies by the Jak2-Stat3-Mcl1 axisGenetic and Pharmacological Screens Converge in Identifying FLIP, BCL2, and IAP Proteins as Key Regulators of Sensitivity to the TRAIL-Inducing Anticancer Agent ONC201/TIC10.Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathwayDual inactivation of Akt and ERK by TIC10 signals Foxo3a nuclear translocation, TRAIL gene induction, and potent antitumor effects.Beyond Antibodies as Binding Partners: The Role of Antibody Mimetics in Bioanalysis.The design and characterization of receptor-selective APRIL variantsTargeting TRAIL in the treatment of cancer: new developments.ONC201 induces cell death in pediatric non-Hodgkin's lymphoma cells.TRAIL-NP hybrids for cancer therapy: a review.c-FLIP and the NOXA/Mcl-1 axis participate in the synergistic effect of pemetrexed plus cisplatin in human choroidal melanoma cells.Thioether analogues of disulfide-bridged cyclic peptides targeting death receptor 5: conformational analysis, dimerisation and consequences for receptor activation.Sortase A-aided Escherichia coli expression system for functional osteoprotegerin cysteine-rich domain.
P2860

Targeting TRAIL death receptor 4 with trivalent DR4 Atrimer complexes.

Item
http://www.wikidata.org/entity/Q34339275
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Targeting TRAIL death receptor 4 with trivalent DR4 Atrimer complexes.
@ast
Targeting TRAIL death receptor 4 with trivalent DR4 Atrimer complexes.
@en
Targeting TRAIL death receptor 4 with trivalent DR4 Atrimer complexes.
@nl
type
label
Targeting TRAIL death receptor 4 with trivalent DR4 Atrimer complexes.
@ast
Targeting TRAIL death receptor 4 with trivalent DR4 Atrimer complexes.
@en
Targeting TRAIL death receptor 4 with trivalent DR4 Atrimer complexes.
@nl
prefLabel
Targeting TRAIL death receptor 4 with trivalent DR4 Atrimer complexes.
@ast
Targeting TRAIL death receptor 4 with trivalent DR4 Atrimer complexes.
@en
Targeting TRAIL death receptor 4 with trivalent DR4 Atrimer complexes.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Targeting TRAIL death receptor 4 with trivalent DR4 Atrimer complexes
@en
P2093
P304
P31
P356
10.1158/1535-7163.MCT-12-0366
P433
P478
P50
P577
P698